There are significant opportunities for pharma and biotech companies to support patients in the Middle East, but how do companies navigate such a culturally diverse region?
Leela Barham uses data shared by the Department of Health and Social Care (DHSC) to take a look back at just how long it can take NICE to reach the milestone of publication of final guidanc
The China-US trade war has spread to the biotech industry, as the US BIOSECURE Act looks to dampen Chinese influence on a range of services, including contract manufacturing.